Eman Eldebawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eman Eldebawy has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Abdelrahman Enayet
Department of Neurosurgery, Children’s Cancer Hospital, Cairo, Egypt
6 shared publications - Amal Refaat
Department of Radiology, Children’s Cancer Hospital, Cairo, Egypt
6 shared publications - Eslam Maher
Experimental Cancer Medicine Centre (ECMC), Department of Surgery and Cancer, Imperial College London London UK
6 shared publications - Hala Taha
Department of Mathematical Sciences, College of Science, Princess Nourah Bint Abdulrahman University, P. O. Box 84428, Riyadh 11671, Saudi Arabia
6 shared publications - Madiha Awad
Department of Pediatric Oncology, Children’s Cancer Hospital, Cairo, Egypt
6 shared publications - Moatasem El-Ayadi
Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
6 shared publications
Latest Publications
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Diagnoses of children with CNS tumors according to the International Classification of Childhood Cancer (ICCC), third edition (ICCC-3). We annotated our cases according to ICCC-3 which is based on ICD-O-3 codes for both topographies and morphologies, to categorize childhood cancers.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Diagnoses of children with CNS tumors according to the International Classification of Childhood Cancer (ICCC), third edition (ICCC-3). We annotated our cases according to ICCC-3 which is based on ICD-O-3 codes for both topographies and morphologies, to categorize childhood cancers.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Data from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Background:Central nervous system (CNS) tumors are the leading cause of cancer-related deaths in children. Although most cases come from low- and middle-income countries (LMIC) where their prognosis is worse, few epidemiologic studies are conducted in these regions.Methods:We conducted a registry-based cohort study for childhood CNS tumors at Children’s Cancer Hospital, Egypt, over 15 years. Unified treatment protocols were implemented. Survival analyses were conducted using the Kaplan–Meier function. Cases were additionally annotated using the International Classification of Childhood Cancer-3 classification.Results:In total, 5,051 children ≤18 years of age were identified, accounting for 20% of all childhood cancers treated at Children’s Cancer Hospital, Egypt. The most common tumor sites were the posterior fossa (36.8%) and brainstem (17.7%). Pathologies were predominantly astrocytic (n = 1,360; 26.9%) and embryonal (n = 1,003; 19.9%) in origin. The 5-year overall survival (OS) and event-free survival for all cases were 64.6% and 51.8%, respectively. More specifically, 1,421 low-grade gliomas were identified, with a 5-year OS of 91.1%. Medulloblastoma (n = 801) recorded a 5-year OS of 66%. The entity with the worst prognosis was diffuse intrinsic pontine glioma (n = 633), with a 5-year OS of 3.2%.Conclusions:We report on a large number of childhood CNS tumors from an LMIC. This study underscores the need to understand the burden of childhood brain tumors and its outcomes in resource-constrained settings.Impact:This study reports on the epidemiology and clinical outcomes of 5,000+ children with CNS tumors from a specialized LMIC center. Despite the lack of many sophisticated and advanced facilities, LMICs can improve the clinical end-results with experience and augmented efforts.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Background:Central nervous system (CNS) tumors are the leading cause of cancer-related deaths in children. Although most cases come from low- and middle-income countries (LMIC) where their prognosis is worse, few epidemiologic studies are conducted in these regions.Methods:We conducted a registry-based cohort study for childhood CNS tumors at Children’s Cancer Hospital, Egypt, over 15 years. Unified treatment protocols were implemented. Survival analyses were conducted using the Kaplan–Meier function. Cases were additionally annotated using the International Classification of Childhood Cancer-3 classification.Results:In total, 5,051 children ≤18 years of age were identified, accounting for 20% of all childhood cancers treated at Children’s Cancer Hospital, Egypt. The most common tumor sites were the posterior fossa (36.8%) and brainstem (17.7%). Pathologies were predominantly astrocytic (n = 1,360; 26.9%) and embryonal (n = 1,003; 19.9%) in origin. The 5-year overall survival (OS) and event-free survival for all cases were 64.6% and 51.8%, respectively. More specifically, 1,421 low-grade gliomas were identified, with a 5-year OS of 91.1%. Medulloblastoma (n = 801) recorded a 5-year OS of 66%. The entity with the worst prognosis was diffuse intrinsic pontine glioma (n = 633), with a 5-year OS of 3.2%.Conclusions:We report on a large number of childhood CNS tumors from an LMIC. This study underscores the need to understand the burden of childhood brain tumors and its outcomes in resource-constrained settings.Impact:This study reports on the epidemiology and clinical outcomes of 5,000+ children with CNS tumors from a specialized LMIC center. Despite the lack of many sophisticated and advanced facilities, LMICs can improve the clinical end-results with experience and augmented efforts.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Detailed diagnoses by pathology. The pathological subtypes discussed in the study are presented in more detail with all the histological diagnoses and their grade.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Detailed diagnoses by pathology. The pathological subtypes discussed in the study are presented in more detail with all the histological diagnoses and their grade.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Detailed pathological diagnosis for all childhood CNS tumors included in the cohort. Bars represent the count of each subtype. Pilocytic astrocytoma was the most common subtype.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Detailed pathological diagnosis for all childhood CNS tumors included in the cohort. Bars represent the count of each subtype. Pilocytic astrocytoma was the most common subtype.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Survival analysis by subgroups reclassified based on the International Classification of Childhood Cancer (ICCC), third edition (ICCC-3). Five-year overall and event-free survival alongside their 95% CIs.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Survival analysis by subgroups reclassified based on the International Classification of Childhood Cancer (ICCC), third edition (ICCC-3). Five-year overall and event-free survival alongside their 95% CIs.
- 8 January 2025
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- p. OF1-OF8
Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Background: Central nervous system (CNS) tumors are the leading cause of cancer-related deaths in children. Although most cases come from low- and middle-income countries (LMIC) where their prognosis is worse, few epidemiologic studies are conducted in these regions. Methods: We conducted a registry-based cohort study for childhood CNS tumors at Children’s Cancer Hospital, Egypt, over 15 years. Unified treatment protocols were implemented. Survival analyses were conducted using the Kaplan–Meier function. Cases were additionally annotated using the International Classification of Childhood Cancer-3 classification. Results: In total, 5,051 children ≤18 years of age were identified, accounting for 20% of all childhood cancers treated at Children’s Cancer Hospital, Egypt. The most common tumor sites were the posterior fossa (36.8%) and brainstem (17.7%). Pathologies were predominantly astrocytic (n = 1,360; 26.9%) and embryonal (n = 1,003; 19.9%) in origin. The 5-year overall survival (OS) and event-free survival for all cases were 64.6% and 51.8%, respectively. More specifically, 1,421 low-grade gliomas were identified, with a 5-year OS of 91.1%. Medulloblastoma (n = 801) recorded a 5-year OS of 66%. The entity with the worst prognosis was diffuse intrinsic pontine glioma (n = 633), with a 5-year OS of 3.2%. Conclusions: We report on a large number of childhood CNS tumors from an LMIC. This study underscores the need to understand the burden of childhood brain tumors and its outcomes in resource-constrained settings. Impact: This study reports on the epidemiology and clinical outcomes of 5,000+ children with CNS tumors from a specialized LMIC center. Despite the lack of many sophisticated and advanced facilities, LMICs can improve the clinical end-results with experience and augmented efforts.
- 8 January 2025
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- p. OF1-OF8
Epidemiology and Clinical Outcomes of Childhood Central Nervous System Cancers in a Large Low/Middle-Income Country Pediatric Oncology Center: A Report on 5,051 Kids
Background: Central nervous system (CNS) tumors are the leading cause of cancer-related deaths in children. Although most cases come from low- and middle-income countries (LMIC) where their prognosis is worse, few epidemiologic studies are conducted in these regions. Methods: We conducted a registry-based cohort study for childhood CNS tumors at Children’s Cancer Hospital, Egypt, over 15 years. Unified treatment protocols were implemented. Survival analyses were conducted using the Kaplan–Meier function. Cases were additionally annotated using the International Classification of Childhood Cancer-3 classification. Results: In total, 5,051 children ≤18 years of age were identified, accounting for 20% of all childhood cancers treated at Children’s Cancer Hospital, Egypt. The most common tumor sites were the posterior fossa (36.8%) and brainstem (17.7%). Pathologies were predominantly astrocytic (n = 1,360; 26.9%) and embryonal (n = 1,003; 19.9%) in origin. The 5-year overall survival (OS) and event-free survival for all cases were 64.6% and 51.8%, respectively. More specifically, 1,421 low-grade gliomas were identified, with a 5-year OS of 91.1%. Medulloblastoma (n = 801) recorded a 5-year OS of 66%. The entity with the worst prognosis was diffuse intrinsic pontine glioma (n = 633), with a 5-year OS of 3.2%. Conclusions: We report on a large number of childhood CNS tumors from an LMIC. This study underscores the need to understand the burden of childhood brain tumors and its outcomes in resource-constrained settings. Impact: This study reports on the epidemiology and clinical outcomes of 5,000+ children with CNS tumors from a specialized LMIC center. Despite the lack of many sophisticated and advanced facilities, LMICs can improve the clinical end-results with experience and augmented efforts.